|
Kandrashkina Yu.A., Orlova E.A.
Characteristics of clinical phenotypes of atopic dermatitis in pregnant women
|
№6 / 2025
|
|
Botkina A.S., Gumennaya E.R.
Clinical experience with methylprednisolone aceponate for atopic dermatitis in young children
|
№7 / 2025
|
|
Sysoeva A.S., Orlova E.A., Levashova O.A., Kulieva O.A., Kandrashkina Yu.A.
The role of intestinal microbiota in the development of atopic dermatitis
|
№7 / 2025
|
|
Macharadze D.Sh.
New treatment options for severe atopic dermatitis: upadacitinib. Review
|
№7 / 2025
|
|
Orlova E.A., Kulieva O.A., Kandrashkina Yu.A., Levashova O.A., Nikolashina O.E., Rybalkin S.B.
The role of skin microbiota in the development of atopic dermatitis in pregnant women and their newborns: prospects for diagnosis and therapy
|
№7 / 2025
|
|
Kandrashkina Yu.A., Orlova E.A.
Moisturizing and antipruritic dermocosmetics in the treatment of atopic dermatitis during pregnancy
|
№3 / 2025
|
|
L.L. Rusakova, N.N. Murashkin
Dynamics of laboratory blood parameters in children with atopic dermatitis who received biological therapy with AN IL-4, IL-13 inhibitor in combination with topical therapy methods
|
№1 / 2025
|
|
S.F. Gladkov, N.K. Perevoshchikova, L.A. Levanova
Parental compliance level as a key factor in the management of atopy march
|
№1 / 2025
|
|
Kruglova L.S., Bakulev A.L., Petrunin D.D., Uspenskaya P.A.
Tacrolimus: issues of practical use in atopic dermatitis – analysis of the positional consensus statement of the group of european experts
|
№10 / 2024
|
|
Rusakova L.L., Murashkin N.N.
Evaluation of the efficacy and safety of combination therapy and prevention of exacerbations of atopic dermatitis in children with moderate and severe forms of the disease
|
№10 / 2024
|
|
Rusakova L.L., Murashkin N.N.
Evaluation of atopic dermatitis severity indices in patients receiving IL-4, IL-13 inhibitor therapy (dupilumab) in combination with topical treatment methods
|
№10 / 2024
|
|
Shadyzheva L.I., Kosheleva I.V., Nemtsova M.V.
Determination of molecular genetic biomarkers – the way to increase the effectiveness of treatment and improving the prevention of atopic dermatitis exacerbations
|
№10 / 2024
|
Русский
